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Antibodies against synthetic peptides derived from 
the DNA sequence of human cytochrome c oxidase 
subunit I1  (COII) have been tested for their capacity to 
immunoprecipitate the whole enzyme complex. Anti- 
bodies against the COOH-terminal undecapeptide of 
COII (anti-COII-C), when incubated with a Triton X- 
100 mitochondrial lysate from HeLa cells pulse-labeled 
with [35S]methionine under conditions selective for mi- 
tochondrial protein synthesis and chased for 18 h in 
unlabeled medium, precipitated the pulse-labeled three 
largest subunits (mitochondrially synthesized) of cy- 
tochrome c oxidase  in proportions close to equimolar- 
ity. Antibodies against the NH2-terminal decapeptide 
of COII (anti-COII-N), although equally reactive as the 
anti-COII-C antibodies with the sodium dodecyl sul- 
fate-solubilized COII, did not precipitate any of the 
three labeled subunits from the Triton X-100 mito- 
chondrial lysate. In other experiments, all the 13 sub- 
units which have been identified in the mammalian 
cytochrome c oxidase  were immunoprecipitated from 
a Triton X-100 mitochondrial lysate of cells long-term 
labeled with [35S]methionine by  anti-COII-C antibod- 
ies, but not by anti-COII-N antibodies. By contrast, in 
immunoblots of total mitochondrial proteins disso- 
ciated with sodium dodecyl sulfate, the anti-COII-C 
antibodies reacted specifically only with COII. These 
results strongly suggest  that,  in the native cytochrome 
c oxidase complex, the epitope recognized by the anti- 
COII-C antibodies is in the COII subunit and that, 
therefore, in such complex, the COOH-terminal peptide 
of COII is exposed to antibodies, whereas the NH2- 
terminal peptide is not accessible. 
The recently introduced use of antibodies directed against 
synthetic peptides predicted from the DNA or protein se- 
quence has proven to be powerful for the study of proteins 
encoded in known genes and for the identification of polypep- 
tides specified by unknown reading frames (see review by 
Walter  and Doolittle, Ref. 1). In particular,  this approach has 
been very useful for the identification of the polypeptides 
encoded in the unidentified reading frames of human mito- 
chondrial DNA (mtDNA) (2-4). A valuable extension of this 
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approach would  be the use of antipeptide antibodies for the 
isolation of complexes containing the specific polypeptide 
against which the antibodies were raised. As a preliminary to 
an investigation of the possible association of the products of 
mtDNA unidentified reading frames with one of the known 
or unknown complexes of the inner mitochondrial membrane, 
the well characterized cytochrome c oxidase complex was 
chosen as  a model system for defining the appropriate condi- 
tions under which a mitochondrial complex  could be immu- 
noprecipitated in intact form  by antipeptide antibodies. We 
report here that  the cytochrome c oxidase complex can be 
immunoprecipitated from a HeLa cell Triton X-100 mito- 
chondrial lysate by antibodies directed against the COOH- 
terminal undecapeptide of subunit I1 (COII-C), but  not by 
antibodies directed against the NHZ-terminal decapeptide of 
the same subunit  (COII-N). 
MATERIALS AND METHODS 
Preparation of Anti-peptide  Antibodies-The preparation of anti- 
bodies against the COOH-terminal undecapeptide (anti-COII-C) or 
the NH2-terminal decapeptide (anti-COII-N) of cytochrome c oxidase 
subunit I1 has been described previously (2). Each type of antiserum 
used derived from a single rabbit. A total y-globulin fraction, free of 
antibodies against the carrier protein used in the immunizations (2), 
was utilized in  these experiments. 
In Vivo Labeling of HeLa Cell Mitochondrial Translation Prod- 
ucts-Different labeling protocols were used. In some experiments, 
HeLa cells were labeled in methionine-free medium for 2  h with [%3] 
methionine (10  pCi/ml,  1400  Ci/mmol; Amersham) in the presence 
of 100 pg/ml emetine, an irreversible inhibitor of cytoplasmic protein 
synthesis (“pulse” protocol), as previously described (2). In other 
experiments, the cells were labeled in the presence of 100 pg/ml 
cycloheximide, a reversible inhibitor of cytoplasmic protein synthesis, 
then centrifuged down, washed once in complete medium, resus- 
pended in the same medium at IO5 cells/ml, and incubated for an 
additional 2 h (“pulse-chase” protocol). In other experiments, HeLa 
cells (lo5 cells/ml) were grown in complete medium for 20-22 h  in 
the presence of 40 pg/ml chloramphenicol, an inhibitor of mitochon- 
drial protein synthesis, then washed in methionine-free medium, 
resuspended in the same medium at 2 X 106/ml, and labeled for 2 h 
with [35S]methionine in the presence of cycloheximide, and finally 
chased for 2 h (“preCAP-pulse-2-h chase” protocol) or for 18 h 
(“preCAP-pulse-18-h chase” protocol) in complete medium. For long- 
term labeling, HeLa cells a t  2 X 105/ml  were  grown for 20 h in the 
presence of 2 X lov5 M methionine and 4 pCi [35S]methionine/ml. 
Immunoprecipitation of Cytochrome  c Oxidase Complex-Isolation 
of the mitochondrial fraction was carried out as previously described 
(5). For the immunoprecipitation experiments, all operations were 
carried out a t  4 “C. Samples of mitochondrial suspension (1-2 X lo5 
cpm, 110-270 p g  of protein,  in the case of pulse-labeled preparations, 
7 X lo6 cpm, 500  pg  of protein in the case of the long-term labeled 
preparation) in 0.01 M Tris, pH 6.7 (25 “C), 0.25 M sucrose, were 
made 0.5% (w/v) in Triton X-100 in a final volume of 25-80 pl 
(protein concentration of 3.5-6 mg/ml) and incubated for 20 min. 
After diluting the sample 4-10-fold with 0.005 M Tris-HC1, pH 6.7 
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3356 Human Cytochrome c Oxidase 
(25 "C), 0.002 M methionine, 0.001 M phenylmethylsulfonyl fluoride, 
0.5% Triton X-100, 1 mg/ml ovalbumin  (incubation buffer, IB), 
methanol was added to 2% final concentration, and the mixtures 
were incubated for an additional 10 min. Each sample was pread- 
sorbed with 125 pl of a 10% (w/v)  suspension in IF3 of formaldehyde- 
fixed Staphylococcus aureu.7, Cowan  strain I (Zysorbin, Zymed Labo- 
ratories) for 30 min  and  then  centrifuged  in  an  Eppendorf microfuge 
for 2 min. T o  each  supernatant 2.50 pg of the y-globulin fraction from 
the  antiserum or normal  serum were added,  and  the  mixtures were 
incubated for 1 h. After addition of a  10-fold protein  excess of a 0.5% 
Triton X-100 mitochondrial lysate from unlabeled cells (7-50 mg/ 
ml)  and of SDS' to a final  concentration of 0.196, the  samples were 
mixed with 125 pl of S. aureu.7 suspension,  incubated for 30 min,  and 
then  centrifuged  in  the microfuge for 2  min. The pellets were  washed 
hy centrifugation  one  time with IB containing 0.1% SDS, one  time 
with IB, and  one  time  with 0.01 M Tris-HCI. pH 6.7, and were then 
extracted with 40 or 60 pl of 8 M urea, 4% SDS, 0.01 M Tris-HCI, pH 
7.3, 0.1% mercaptoethanol for 20-60 min a t  37 "C and 5-10 rnin at 
50 "C. A portion of each  extract was run  on  an  SDS-urea-polyacryl- 
amide gel. 
Isolation of Beef Heart and Human Placenta Cytochrome c Oxi- 
dase-Reference is made to published  procedures  for  the  purification 
ofcytochrome c oxidase from beef heart  (6)  and from human  placenta 
(7). 
Gel Electrophoresis-The immunoprecipitated samples were run 
on SDS-15% polyacrylamide (1:50 bisacrylamide). 8 M urea  slab gels 
(8, 9). The gels were prepared for  fluorography as described (10). In 
one  experiment,  the gel was stained  with  silver  as described (11). 
RESULTS 
Conditions of Immunoprecipitation of Cytochrome c Oxidase 
by Anti-COII Antibodies-Like other enzyme complexes of 
the  oxidative  phosphorylation  system,  the  cytochrome c oxi- 
dase complex has a chimeric  structure,  consisting of subunits 
in  part  synthesized  in  mitochondria  and  encoded in mtDNA, 
in part synthesized in the cytoplasm and encoded in the 
nucleus. In  the  mammalian  enzyme, which contains 13 differ- 
ent polypeptides (12-14). the 3 largest  subunits  are of mito- 
chondrial origin and  the  other  10  subunits of nuclear origin 
(7).  Fig. 1 shows  the  sequence of human COII, as derived  from 
the  DNA  sequence (15). and  the  NH,-terminal  and  COOH- 
terminal peptides which were used for the preparation of 
antibodies.  In previous work (2),  it was shown that  the  anti- 
COII-C and  anti-COII-N  antibodies were  equally  effective in 
precipitating  COII,  when  incubated  with  an  SDS  mitochon- 
drial  lysate from HeLa cells  labeled for 2  h with  [%]methio- 
nine  in  the  presence of 100 pg/ml emetine. The reaction was 
absolutely specific, since  no  other  mitochondrial  translation 
COII-N 
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FIG. 1. Amino acid  sequence  of human COII, derived from 
the DNA sequence (15). The NH2-terminal and COOH-terminal 
peptides which were chemically synthesized and coupled to bovine 
serum  alhumin for the  preparation of antibodies  are boxed. 
' The  abbreviation used is: SDS, sodium dodecyl sulfate. 
~ ~~ 
product  reacted with these  antibodies, with the  exception of 
an NH2-terminal fragment of COII, which reacted weakly 
with the anti-COII-N antibodies. In the present work, im- 
munoprecipitation  experiments were carried  out using  a Tri- 
ton X-100 mitochondrial  lysate from cells labeled and  chased 
according to different protocols and y-globulins from the 
chosen peptide-specific antiserum or from normal senim. 
Control  experiments showed that  the  amount of anti-COII-C 
or anti-COII-N antibodies employed in the present experi- 
ments was  in  excess over  that required to  precipitate  the  great 
majority of the labeled COII  subunits from SDS-solubilized 
or Triton X-100-solubilized mitochondria. 
Immunoprecipitation by Anti-COII Antibodies of PuLqe-la- 
beled Mitochondrially Synthesized  Subunits of Cytochrome c 
Oxidase-Because of the low level of labeling attainable in 
the cytochrome c oxidase subunits after long-term labeling 
with ["S]methionine of exponentially growing HeLa cells 
(due  to  the  dilution of the label by the unlabeled methionine 
necessary to support cell growth),  the  initial  experiments of 
immunoprecipitation of the whole  complex by anti-COII-C or 
anti-COII-N  antibodies described in this work were carried 
out by using material from cells labeled for 2 h with ["S] 
methionine in the presence of an inhibitor of cytoplasmic 
protein  synthesis,  emetine, or cycloheximide, i.e. under  con- 
ditions under which only the mitochondrially synthesized 
subunits would be labeled. Due to the strict dependence of 
the synthesis and stability of these subunits and of their 
integration  into a complex on  the  synthesis  and  import  into 
mitochondria of the extramitochondrially synthesized sub- 
units (16), the cells were subjected to different treatments 
before and  after  the  2-h ["'S]methionine pulse, as specified 
below, in an effort to promote the incorporation into the 
complex of the  subunits labeled during  the pulse. 
Fig. 2, lane a, shows the labeling pattern of HeLa cell 
a b c d  =-== 
ATPase6 
NO3 - 
ATPase 8 - . a i s  (I) 
ND4L { 
FIG. 2. Patterns of mitochondrial translation products from 
HeLacells labeled under different conditions. Samples (-20,000 
cpm) of SDS mitochondrial lysates from cells labeled according to 
the  pulse protocol (lane a ) .  or the  pulse-chase protocol (lone b) ,  or the 
preCAP-pulse-2-h  chase protocol (lane c), or the  preCAP-pulse-18-h 
chase protocol (low d )  were run in parallel on  an  SDS-urea-polyac- 
rylamide gel. N D I ,  ND2, ND3,  ND4,  ND4L, and ND.5, mitochon- 
drially  synthesized  subunits of the  respiratory  chain NADH dehydro- 
genase (17); COI, COll, COIII. subunits of Cytochrome c oxidase; 
C Y T b  cytochrome b; ATPme 6 and ATPosr 8, subunitq of [H'J 
ATPase.  See  text for  details. 
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FIG. 3. Pattern  of immunoprecipitation of mitochondrially  synthesized  cytochrome  c oxidase sub- 
units by anti-COII-N and anti-COII-C antibodies under different labeling and chase conditions. Top 
panels, samples of Triton X-100 mitochondrial  lysates  from cells  labeled  according to  the pulse  protocol ( 1 s t  punel). 
or the  pulse-chase protocol (2nd  panel), or the  preCAP-pulse-2-h  chase protocol ( 3 r d p a n e l ) .  or the  preCAP-pulse- 
18-h chase protocol (4th panel) were immunoprecipitated  with  anti-COII-N or anti-COII-C  antibodies.  as descrihed 
under  "Materials  and  Methods"  and  run  on  SDS-urea-polyacrylamide gels. M, pattern of mitochondrial  translation 
products present in the lysate used in each experiment; NS, normal serum y-globulin control. Bottom ponds .  
densitometric  tracings of appropriate  exposures of the  autoradiograms. In each  panel,  the molar ratim of labeled 
COI, COII,  and  COIlI  in  the  complexes  precipitated by anti-COII-C  antibodies.  calculated as explained in the text. 
are  indicated. 
mitochondrial  translation  products  isolated  from cells  labeled 
for 2 h with ["S]methionine in the presence of 100 pg/ml 
emetine. The individual products  have been  assigned to  the 
reading  frames of human  mtDNA  and  are  designated  accord- 
ing to their functional identification (17). This assignment 
was made in most cases on the basis of experiments using 
antibodies  directed  against  peptides  predicted from the  DNA 
sequence (2-4, 17); COI, COII,  and  COIII  and  cytochrome b 
were identified by analysis of the  site of synthesis  and elec- 
trophoretic  properties of the  subunits of purified human cy- 
tochrome c oxidase complex (7) and, respectively, purified 
human  cytochrome 6. c, complex.* 
Fig. 3, top, 1st panel, shows the  electrophoretic  pattern of 
* C. Doersen and C .  Attardi,  manuscript  in  preparation. 
the  immunoprecipitate  obtained by incubating a 0.5% Triton 
X-100 mitochondrial  lysate  from  the 2-h  pulse-labeled HeLa 
cells with  anti-COII-C or anti-COII-N y-globulins. One  can 
see  that, while the  anti-COII-N  antibodies  precipitated from 
among the pulse-labeled components only COII, the anti- 
COII-C antibodies  precipitated all three mitochondrially syn- 
thesized subunits (COI, COII, and COIII). with a strong 
preponderance, however, of COII. No bands of precipitated 
material were  visible  in the control  carried  out with  normal 
serum y-globulins (not  shown). A reasonable  interpretation 
of these results is that, while the anti-COII-N antibodies 
precipitated from the  Triton X-100-solubilized mitochondria 
only newly synthesized  COII  subunits which were not asso- 
ciated  in complexes with labeled  COI and/or COIII subunits, 
the  anti-COII-C  antibodies  precipitated COII subunits  assem- 
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3358 Human Cytochrome  c Oxidase 
bled with labeled COI and/or COIII subunits,  and possibly 
with other  subunits,  as well as  any free COII subunits. From 
densitometric tracings of appropriate exposures of the  auto- 
radiogram and from the methionine content of the three 
subunits,  it could  be estimated that, in the material precipi- 
tated by anti-COII-C antibodies, the newly synthesized COI, 
COII, and COIII are present in proportions very different 
from equimolarity, with a large excess of COII and  a small 
excess of COIII (Fig. 3, bottom,  1st  panel). 
When HeLa cells were labeled for 2 h with [35S]methionine 
in the presence of 100 pg/ml cycloheximide, and  then chased 
for 2 h in unlabeled medium, to allow time for integration of 
the newly synthesized subunits  into the complex, the labeling 
pattern of the mitochondrial translation products was not 
significantly different from that obtained from nonchased 
cells (Fig. 2, lane b). However, the relative amount of labeled 
COII precipitated from this  material by anti-COII-N  antibod- 
ies was much smaller than  that observed with material from 
nonchased cells (Fig. 3, top,  1st  panel); furthermore, the 
labeled COI, COII, and COIII specifically precipitated by anti- 
COII-C antibodies were in  proportions much closer to equi- 
molarity (Fig. 3, bottom,  2nd  panel). 
Experiments were carried out to  test whether the integra- 
tion of the mitochondrially synthesized subunits into com- 
plexes could  be promoted by a preincubation of the cells with 
chloramphenicol, an inhibitor of mitochondrial protein  syn- 
thesis, so as  to allow accumulation of cytoplasmic subunits in 
the cytosol and/or mitochondria, as has been reported to 
occur in Saccharomyces cerevisiae (18) and Neurospora crassa 
(19). For this purpose, HeLa cells were  grown in  the presence 
of 40 pg/ml chloramphenicol for 22 h before the 2-h ["SI 
methionine pulse and  a 2- or  18-h chase. The above conditions 
of chloramphenicol treatment have previously been shown to 
inhibit mitochondrial protein  synthesis in HeLa cells by more 
than 90%, while  allowing growth of the cells at a normal rate 
for 2 days (20). The chloramphenicol pretreatment had a 
marked effect on the relative labeling of the various polypep- 
tides. Thus,  the relative intensities of the bands corresponding 
to  the ATPase 6 (3) and  ATPase 8 subunits  (2,21) were much 
higher in the material from cells pulse-chased after growth in 
the presence of chloramphenicol (Fig. 2, lanes c and d )  than 
in the material from nonchloramphenicol-pretreated cells 
(Fig. 2, lanes  a and b). Similarly, the band corresponding to 
the ND2 product increased dramatically in  the preCAP-pulse- 
chase protocols relative to  the pulse and pulse-chase protocols. 
This marked increase in the relative labeling of the above- 
mentioned mitochondrial translation products may reflect an 
increase in their metabolic stabilities, possibly related to  the 
greater availability of cytoplasmic polypeptides with which 
the mitochondrially synthesized polypeptides become associ- 
ated  to form various complexes. 
When anti-COII-C antibodies were incubated with Triton 
X-100 mitochondrial lysates from chloramphenicol-pre- 
treated cells chased for 2 h, the relative amounts of labeled 
COI, COII, and COIII in the precipitated complexes were 
found to be much closer to equimolarity (Fig. 3, top,  3rdpanel 
and bottom, 3rd panel), as compared to  the precipitates ob- 
tained with material from nonchloramphenicol-pretreated 
cells. Similar results were obtained with material from chlor- 
amphenicol-pretreated cells chased for 18 h (Fig. 3, top,  4th 
panel and bottom,  4th  panel); furthermore,  there was a com- 
plete disappearance of labeled COII in  the immunoprecipitate 
obtained with anti-COII-N antibodies after the 18-h chase 
(Fig. 3, top,  4thpanel). 
In  Table I, the molar proportions of labeled COI, COII, and 
COIII in the complexes specifically precipitated by anti-COII- 
TABLE I 
Relative  molar  amounts of pulse-labeled  COI, COZZ, and  COIII in the 
SDS mitochondrial  lysate  and in   the  complexes  immunoprecipitated 
by  anti-COII-C  antibodies 
Conditions of labeling 
SDS mitochondrial 1:1:0.4 1:0.60.4 L0.40.5 1:0.5:0.4 
Immunoprecipitated 1:43:3.2  1:3.4:0.8 1:1.70.6 1:0.5:0.4 
lysate 
complexes 
The molar  proportions of COI,  COII, and COIII were determined 
from densitometric  measurements  made  on  appropriate exposure of 
the autoradiograms, after correction for the different methionine 
content of the  three  subunits. 
C antibodies from cells labeled and chased according to dif- 
ferent protocols are compared to  the molar ratios of the same 
polypeptides among the mitochondrial translation products 
present  in the SDS mitochondrial lysate. It is clear that,  in 
all cases, except in the case of cells pretreated with CAP and 
chased for  18  h  after the pulse, the  three labeled subunits  are 
present  in different proportions in the complexes  specifically 
precipitated by anti-COII-C antibodies and in the SDS mi- 
tochondrial lysate. Thus,  the relative intensities of the COI, 
COII, and COIII bands in  the  pattern of 2-h-pulse-labeled 
mitochondrial translation products correspond to approxi- 
mately equimolar amounts of newly synthesized COI and 
COII and  a somewhat lower molar amount of newly synthe- 
sized COIII, probably reflecting the relative rates of synthesis 
of the three subunits. By contrast, in the pattern of the 
immunoprecipitated complexes, there is a large excess of 
labeled COII and a much smaller excess of labeled COIII, 
indicating a delay in the incorporation of the newly synthe- 
sized  COI and,  to a lower  degree, of COIII into  the complexes. 
The decrease in the relative labeling of COII in the  pattern 
of mitochondrial translation products from cells chased for 2 
h  after  a  2-h pulse, relative to  the  pattern from the 2-h-pulse- 
labeled nonchased cells, suggests a higher rate of decay of the 
labeled COII relative to  the other two subunits during the 2- 
h chase. The discrepancy between the relative molar amounts 
of newly synthesized subunits in the immunoprecipitates and 
in  SDS mitochondrial lysates from 2-h-chased cells presum- 
ably reflects the fact that different proportions of the labeled 
COI, COII, and COIII subunits are incorporated into com- 
plexes specifically precipitated by anti-COII-C antibodies. By 
contrast, the identity of the molar proportions of labeled 
subunits in the precipitated complex and in the SDS mito- 
chondrial lysate from 18-h-chased cells (Table I), combined 
with the observation of the absence of labeled COII precipi- 
table by anti-COII-N antibodies in the  Triton X-100 mito- 
chondrial lysate, suggests that all three labeled subunits  are 
completely incorporated into complexes after that length of 
chase. The relatively modest deviations from equimolarity of 
the labeled subunits in both the whole SDS lysate and  the 
immunoprecipitated complex  may reflect small differences in 
the  rate of synthesis  and/or  stability of the  three subunits. 
Fig. 4 shows that 5 pg  of the NH,-terminal decapeptide or, 
respectively, the COOH-terminal undecapeptide of COII com- 
peted completely with this  subunit, free or incorporated into 
complexes, in the precipitation by the anti-COII-N or, re- 
spectively, anti-COII-C antibodies. 
Immunoprecipitation  by  Anti-COII  Antibodies of Long- 
term-labeled Subunits of Cytochrome c Oxidase-The results 
reported in  the previous section indicated that anti-COII-C 
antibodies were able to precipitate all three mitochondrially 
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FIG. 4. Specific  peptide  inhibition of immunoprecipitation 
of COI, COII, and COIII by anti-COII-N and anti-COII-C 
antibodies. Samples of a Triton X-100 mitochondrial lysate ( 1  X 
1 0 K  cpm, 125 p g )  from cells labeled under the pulse-2-h  chase protocol 
were immunoprecipitated by anti-COII-N or anti-COII-C  y-globulins 
(250 pg) in the absence or presence of 5 pg of  COII-N or, respectively, 
COII-C peptide. M, pattern of mitochondrial translation products. 
synthesized  subunits of cytochrome c oxidase  from a Triton 
X-100 mitochondrial lysate. After an 18-h chase, the three 
subunits labeled during the 2-h (JsS]methionine pulse ap- 
peared to be incorporated  in  proportions close to equimolarity 
into complexes precipitable by anti-COII-C  antibodies.  This 
suggested that  the whole intact  cytochrome c oxidase complex 
was precipitated by anti-COII-C  antibodies.  In  order to con- 
firm  this  interpretation,  the  same  antibodies were tested  on a 
Triton  X-100  mitochondrial  lysate from exponentially grow- 
ing cells  labeled for 22 h with  ["S]methionine  in  the  absence 
of inhibitors. 
As shown in Fig. 5a, the precipitate obtained with anti- 
COII-C antibodies revealed 12 bands, which corresponded 
well in mobility to the 13 polypeptides which have been 
identified in mammalian cytochrome c oxidase (14). (The 
VIIa and VIIb subunits could be resolved in some of the 
electrophoretic  runs.)  In  fact,  these  bands aligned well with 
the  subunits  detected by silver  staining  in purified beef heart 
cytochrome c oxidase (Fig. 56). (Similar  results were obtained 
with the human placenta cytochrome c oxidase, although 
components VIa,  VIb, and VIc and VIIa,  VIIb, and VIIc were 
not well resolved in this  sample  (not  shown).)  The  somewhat 
slower migration of human COI and  the  faster  migration of 
human  COII relative to  the homologous  bovine subunits  have 
been  previously documented (7). The 13 polypeptides  precip- 
itated by anti-COII-C  antibodies were absent in the precipi- 
tate  obtained in the  presence of the specific  peptide. Again, 
as observed in the  experiments  with pulse-labeled material, 
no  cytochrome c oxidase-specific  polypeptides  were  precipi- 
tated by anti-COII-N  antibodies.  In  the  experiment  shown i
Fig. 5, a few bands which are present in the precipitate 
obtained  with  anti-COII-C  or  anti-COII-N  antibodies  or  with 
normal  serum y-globulins,  in most  cases  with  the  same  inten- 
sity,  represent  minor  contaminants  precipitated  or  adsorbed 
on  the S. aureus immunoadsorbent nonspecifically. 
Assay of Blots of Total Mitochondrial Proteins with Anti- 
COII-C Antibodies-The experiments described  above  clearly 
showed that  the  anti-COII-C  antibodies  precipitated specifi- 
cally the whole cytochrome c oxidase  complex  from a Triton 
X-100  mitochondrial lysate. No  other  mitochondrial  protein 
was  precipitated by these  antibodies,  indicating  that  the  epi- 
tope  that  the  latter r cognized pertained  to  one of the  subunits 
of the  cytochrome c  oxidase  complex. The previously reported 
evidence on  the specificity of the  anti-COII-C  antibodies  (2) 
and  the  absence of any  significant homology of the  COII-C 
peptide  with COI and  COIII  (2)  argued  against  the  presence 
in  the  latter  subunits of an  epitope  cross-reacting with the 
anti-COII-C  antibodies  in  the  intact complex. To exclude the 
presence of such a cross-reacting  epitope in any of the  cyto- 
plasmically synthesized  subunits of the complex, total mito- 
chondrial proteins, denatured with SDS, separated on an 
SDS-urea-polyacrylamide gel and  transferred  electrophoreti- 
cally onto a  nitrocellulose membrane, were tested  with  anti- 
COII-C antibodies, using peroxidase-conjugated goat anti- 
rabbit IgG for the  detection of the  reacting  proteins  (22). As 
shown in Fig. 5c, the anti-COII-C antibodies reacted very 
strongly  and specifically with COII. No  such a reaction was 
observed in parallel lanes assayed with  anti-URF3-C (3) or 
anti-URF4L-C antibodies (4) (not shown). The very faint 
bands  migrating  faster  or slower than  COII  result from non- 
specific reaction,  since  they were also  present in the  control 
lanes. These  results,  therefore,  strongly suggest that  the  epi- 
tope recognized by anti-COII-C  antibodies in the  intact cy- 
tochrome c oxidase  complex is  in  the  COII  subunit itself. 
The monospecificity of the  anti-COII-C  antibodies was also 
observed in immunoprecipitation experiments utilizing an 
SDS mitochondrial lysate from cells long-term-labeled with 
["S]methionine  in the  absence of inhibitors  (not  shown). 
DISCUSSION 
The results  reported above indicate that antibodies  directed 
against  the  COOH-terminal  undecapeptide of COII can  pre- 
cipitate from a Triton X-100 mitochondrial  lysate  the  entire 
cytochrome c oxidase  complex in a substantially  pure form. 
The finding  that  the  three  mitochondrially  synthesized  sub- 
units labeled during a 2-h  pulse  in  the  presence of cyclohexi- 
mide and  then  chased for 18 h in the  absence of inhibitors 
were precipitated in close to equimolar proportion by anti- 
COII-C antibodies,  in  the  absence of any  precipitation of COII 
by anti-COII-N  antibodies,  strongly  suggests  that  the complex 
released by Triton X-100  lysis of the  organelles  and  immu- 
noprecipitated was not  appreciably  disrupted.  The  presence 
of the 10 cytoplasmically synthesized subunits, besides the 
mitochondrially synthesized ones, in the complex immuno- 
precipitated from long-term-labeled cells is consistent with 
the above  conclusion. 
The  main  observation reported in  this  paper  is  that  anti- 
bodies directed  against  the  COOH-terminal  undecapeptide of 
COII react  with  this  epitope  when  the  subunit is integrated 
in the cytochrome c oxidase complex, whereas antibodies 
directed  against  the  NH2-terminal  decapeptide of COII,  when 
tested  on  the  intact complex, do  not recognize this epitope. 
This observation may have interesting implications for the 
molecular structure  and  subunit  organization f this complex. 
Since  the  two  above-mentioned  synthetic  peptides were 
equally immunogenic in rabbits  (2).  and  since  each of the two 
types of antibodies was capable of recognizing the  correspond- 
ing peptide of COII in an SDS mitochondrial lysate (2), it 
must be concluded that,  in  the complex immunoprecipitated 
from a Triton X-100  lysate, the  NH2-terminal  peptide of COII 
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FIG. 5. Immunoprecipitation of the cytochrome c oxidase complex by anti-COII-C antibodies. a. 
samples of a Triton X-100 mitochondrial lysate from cells long-term-Isheled with ['%]methionine (500 pg of 
protein) were immunoprecipitated by 250 pg of anti-COII-C or anti-COII-N  7-globulins  (in  the  ahsence or presence 
of 20 pg of the  corresponding  peptide), or by 250 pg of normal  serum (NS) y-globulins  (in  the  ahsence or presence 
of 20 pg each of COII-C  and  COII-N),  and  run  on  an  SDS-urea-polyacrylamide gel. M, pattern of mitochondrial 
translation  products. b, a sample of purified cytochrome c oxidase from beef heart (BH) was run  on  an  SDS-urea- 
polyacrylamide gel in  parallel with samples of a Triton X-100 mitochondrial  lysate from long-term-labeled  celh 
immunoprecipitated by anti-COII-C  antibodies  in  the  absence or presence of the  corresponding  peptide  and  its 
subunit  pattern revealed by silver staining. c, a sample of an  SDS  mitochondrial  lysate (150 pg protein) from HeLa 
cells labeled with  [?'3]methionine as in  the  experiment of  Fig. 2, lane a. was run  on  an  SDS-urea-polyacrylamide 
gel and  electrophoretically  transferred  to a nitrocellulose membrane  (Schleicher  and Schuell. BARS) with  a  Rio- 
Rad  apparatus.  The hlot was  sequentially  incubated  with  anti-COII-C  7-globulins  and with  peroxidase-conjugated 
goat  anti-rabbit-IgC  and  then processed  for the peroxidase  reaction according to a published  protocol (22) (CY)]/- 
C ) .  After drying,  the COII band was marked with  radioactive ink,  and  the blot was exposed  for autoradiography 
(M). 
is masked by one or more of the  other  subunits of the complex, 
or by Triton  X-100 or phospholipids, or that  the  conformation 
of COII is changed in such a way that its NH2-terminal 
peptide  is  no longer  exposed or, in  any case,  recognizable by 
the  antibodies. As the  absence of reactivity of anti-COII-N 
antibodies  with  the complex was observed in  experiments in 
which the complex was presumably precipitated intact, it 
seems likely that  the  exposure of the  COOH-terminal  peptide 
but not of the NH2-terminal peptide of COII reflects the 
organization of the  native enzyme. 
The  present  observations  should be considered  in  the  con- 
text of what is known about  the  arrangement of the  cyto- 
chrome c oxidase  subunits  within  the complex in the  inner 
mitochondrial membrane. Electron microscopic and image 
reconstruction  studies  have led to a model of the  cytochrome 
c oxidase complex as a Y-shaped structure made of three 
domains: two of these  (M1  and M2, corresponding to the  arms 
of the Y) span  the lipid  bilayer,  while the  third  one  (C  domain) 
extends outside the bilayer (23, 24). Cytochrome c (25-28) 
and  antibody  binding  experiments  (29) clearly indicate  that 
the C domain  is located on  the cytoplasmic side of the  inner 
mitochondrial  membrane. As to  the topology of COII  within 
the complex, antibody  binding (29-30) and  iodination  exper- 
iments (31) and labeling studies with hydrophylic protein- 
modifying reagents (31-34) have  shown that  this  subunit is a 
part of the C domain  and  therefore projects into  the  inter- 
membrane space; on  the  other  hand,  results  obtained by the 
use of hydrophobic probes (34-36) have  indicated that COII 
is in part embedded  in the bilayer. These reactivities of COII 
can be correlated with the known amino acid  sequence of this 
subunit (15), which is largely conserved in different mam- 
malian species (37-39). As shown in Fig. 6 for the human 
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FIG. 6. Hydropathy plot (40) of human cytochrome c oxi- 
dase subunit 11. A span of 19 residues was used. Note the two 
putative  membrane-spanning  segments  in  the  NH,-terminal  third of 
the sequence. 
COII,  the  hydropathy  plot (40) of this polypeptide  reveals  two 
prominent  peaks  that  are  characteristic of membrane  span- 
ning segments in the NH, terminus proximal third of the 
molecule. Therefore,  it is reasonable  to  think  that  these two 
segments cross the  inner  mitochondrial  membrane, whereas 
the COOH terminus  proximal  portion of the  subunit molecule 
projects out of the  membrane.  In  agreement  with  this  inter- 
pretation is the  observation  that  the majority of the conserved 
acidic residues of COII, which have been implicated  in  cyto- 
chrome c binding,  are  in  the  COOH-terminus  proximal half 
of the molecule (41).  It  has been  shown that,  in  Triton X-100, 
the  isolated  cytochrome c oxidase exists  in dimeric  form as  a 
detergent-phospholipid-protein complex, in which a portion 
of the original phospholipids have been displaced by the 
detergent (42). It is a reasonable assumption that, in the 
detergent-solubilized  cytochrome c oxidase  complex, the  NH, 
terminus  proximal  portion of COII is masked by the  detergent 
displacing the  phospholipids, or by the residual tightly  bound 
phospholipids, or by the  interaction of this  portion of COII 
with other  subunits in the  same or in  the opposing monomer; 
by contrast, the COOH terminus of COII would be freely 
accessible to  antibodies.  The  alternative possibility that  the 
NHz  terminus  proximal  peptide of COII  is still exposed in  the 
Triton X-100-solubilized  complex but  has become completely 
unreactive  due  to  a  conformational  change  cannot be rigor- 
ously excluded, but  seems unlikely: in  fact,  such an exposed 
terminal sequence would be expected  to be mobile and  there- 
fore likely to move through  a  range of conformations (43). 
Although the definitive interpretation  ofthe significance of 
the differential reactibity of anti-COII-C and anti-COII-N 
antibodies with the  intact complex, in  terms of the  detailed 
interaction of the  subunits  and of the  formation of functional 
sites, must await further information, it is  clear that an 
extension of this  approach  to  other  segments of COII and of 
the  other  subunits of the  cytochrome c oxidase  complex can 
produce a  detailed molecular map of the  surface of this com- 
plex. Furthermore,  the use of fragments of the complex  ob- 
tained by cross-linking  methods  or by controlled  disruption 
can  make  "internal"  epitopes accessible to  antipeptide  anti- 
bodies, thus allowing a molecular mapping of the  interior of 
the complex. In  a more  general context,  the use of specifically 
targeted  antibodies  should prove invaluable for the  analysis 
of the organization of multimeric complexes. Antipeptide 
antibodies have  recently  been  used to  map  the  phosphotrans- 
ferase activity in the transforming protein pp60"'" and to 
locate the  sites of this  protein involved in  its  interaction  with 
two  cellular proteins, pp90 and pp50 (44). 
A delay was observed in  the  appearance of newly synthe- 
sized  COI and,  to  a lower degree,  COIII,  relative to  COII,  in 
the complexes immunoprecipitated from the Triton X-100- 
solubilized mitochondria. Previously, a different kinetics of 
appearance of the various pulse-labeled subunits into the 
cytochrome c oxidase complex, with COI being particularly 
delayed  relative to COII and  COIII,  had been reported for N. 
crassa (45), S. cereuisiae (46), and  rat  hepatocytes (47,  48). In 
N .  crassa, the  different  time courses of labeling of the  subunits 
in  the isolated cytochrome c oxidase  could be correlated with 
different sizes of the pools of the  various "precursor"  polypep- 
tides ( i e .  the polypeptides not yet incorporated  into  the 
holoenzyme), with  indications  that  the pool of COI precursor 
polypeptides consisted of two or more pools connected in 
series (45). Evidence that  the delayed incorporation of pulse- 
labeled subunit  I  into  the complex  is due  to  a  late assembly 
in  a  sequential  and  ordered process, rather  than  to  a simple 
effect of dilution of the newly synthesized  subunits by a larger 
precursor pool, has been  recently presented for the enzyme in 
isolated rat liver mitochondria or  isolated rat  hepatocytes (47, 
48). It  seems  reasonable  to  assume  that  the  situation observed 
in isolated rat hepatocytes also  holds for  HeLa cells, as 
described in the present work. Furthermore, it seems very 
likely that the kinetic behavior of newly synthesized COI, 
COII,  and COIII  observed in  HeLa cells  does not  result from 
the use of inhibitors of cytoplasmic protein  synthesis  during 
the labeling, but reflects the  situation  occurring  in  exponen- 
tially growing cells. In isolated rat  hepatocytes,  the lag in  the 
incorporation of pulse-labeled  COI into  the holoenzyme was 
observed whether or not cycloheximide was present during 
the labeling (47). 
Our finding  that  pretreatment of HeLa cells for 22 h  with 
a  concentration of CAP sufficient to  inhibit  almost completely 
mitochondrial  protein  synthesis,  but  still  permitting growth 
of HeLa cells a t  a  normal  rate for 2 days (20), did not allow a 
substantially higher incorporation of the newly synthesized 
COI, COII, and COIII into complexes precipitable by anti- 
COII-C antibodies strongly suggests that  the availability of 
the cytoplasmic subunits was not  rate-limiting  in  the assembly 
of newly synthesized COII with COI and/or  COIII;  alterna- 
tively, it  is conceivable that no accumulation of cytoplasmic 
subunits occurred during  the  CAP  pretreatment. 
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Note  added  in proof-Since this  paper was submitted  for  publica- 
tion, our attention  has  been  called  to  a  paper by Millet  et al. (Millet, 
F., deJong, C., Paulson, L., and Capaldi, R. A. (1983) Biochemistry 
22, 546-552), in which the authors propose a folding pattern for 
bovine COII similar to that proposed here, with two hydrophobic 
stretches in the NH2-terminal third of the molecule traversing the 
inner  mitochondrial  membrane. 
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